title: [Stage IV NSCLC. Economic analysis in lung cancers].
abstract: OBJECTIVE
  To explain the help of economic analyses in the understanding of lung cancer (LC) management with a description of the quality of selected papers.
  
  
  METHODS
  In the first part, quality criteria of economic analyses are depicted with the key words for the literature selection.
  
  
  RESULTS
  The global costs of LC through literature review are depicted; then, in a second part, the costs of each stage of the disease. Finally, costs of chemotherapeutic drugs and target molecules are also discussed.
  
  
  CONCLUSIONS
  Economic analyses are unavoidable to assess the burden of the disease but also the cost of each management strategy for LC.
authors.affiliation: Service de l'Information Médicale et de l'Evaluation, Service de Pneumologie, Hôpital du Cluzeau, CHU Limoges, France. alain.vergnenegre@unilim.fr
authors.forename: A
authors.initials: A
authors.lastname: Vergnenègre
authors.forename: K
authors.initials: K
authors.lastname: Atsou
authors.forename: L
authors.initials: L
authors.lastname: Molinier
authors.forename: C
authors.initials: C
authors.lastname: Chouaïd
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000191:economics* / Q000473:pathology; D003365:Costs and Cost Analysis; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000191:economics* / Q000473:pathology; D009367:Neoplasm Staging